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of energizing and tranquillizing drugs. Gralnick (10) has pointed to the dan-They found that while the total number gers arising from a failure to take these of articles had increased by 36% in 1960, factors into account. Uncritical and ex-"most of the articles in both years and aggerated claims for a new treatment practically all of the increase fall at the method are likely to be followed by an lower levels of methodological adeequally uncritical rejection of the metho? quacy". Collaborative interdisciplinary as a whole, including any real value It research involving trained research workmight have. He warns that the same may ers was highly desirable in psychopharhappen with the new drugs unless they macology, in the authors' view. are subjected to thorough search and Thioridazine, first reported on, clinitudy a.n~unl~ss the treatment approach cally, in 1958 by Fleesan et «1 (8) and IS multidimensional from t?e start.
Cohen (6) has since been the subject of !he use of the dou?le-bh~d procedure many reports. Doub.le-blind stud~es com-USIng placebo makes It poss~ble for most paring the drug with placebo In adult of these factors to be taken Into acco.unt, psychiatric patients (8, 14, 15, 29, 31, 1, since their influence will tend to contmue 11, 13) have all shown thioridazine to be whether the patient is taking placebo or more effective than placebo with few drug. side effects. The first five studies includ-Nash (21) , in his balanced appraisal of ed adequate objective measures of the double-blind procedure, emphasizes change. Further investigations employing the necessity for the investigator to "an-such measures, but without placebo, (23, ticipate damage to the experiment by fac-34, 37) concluded the drug was effective tors impeding attainment of double-blind and safe. Comparison with other phenoconditions, and to adapt his procedure to thiazines using placebo (8, 9, 11, 14, 31) the requirements of the occasion". While and without placebo (1, 17, 26, 34, 38, ideal SUbject and examiner blindness may 40) indicate the similarity of effect of not be obtained, the author points out these drugs, and confirm the lower freq uency of significant side effects. The "Mellaril, Sandoz Pharmaceuticals. " 'Clinical Director, Thistletown Hospital, Rexdale, Ont. latter have included a pIgmentary retmo-T~~o~t~~cal Teacher, Dept. of Psychiatry! University of pathy on very high dosage (39, 20) Park-"Chief Psychologist, Thistletown Hospital, Rexdale, insonism (including the syndrome of Ontario. akathisia) which is generally (12, 16, 30) but not invariably ( 17, 38) much less frequent than with other phenothiazines. Epileptic seizures were reported by Barsa (4) in two of 100 chronic adult schizophrenic patients, neither of whom had been known to have seizures before and who had tolerated equal doses of chlorpromazine. Waldrop et aJ (38) reported grand mal seizures in two of 71 chronic schizophrenic patients but Pauig (25) , using the drug in 100 epileptic patients, of whom an unstated number were children, reported a reduction in the number of seizures, attributed to the control of emotional factors. Hypotension (35) , inhibitionof ejaculation (33) and rarely, subclinical jaundice (5), granulopenia (3, 36) , and thrombocytopenia (1), have occurred. Waldrop et al (38) reported blurring of vision, dryness of the mouth, nausea and/or vomiting more commonly with thioridazine than with chlorpromazine; the contrary was the case with lactation, nasal congestion, syncope, dermatitis and photo-sensitivity. Sauter (30) reported the hypnotic effect of thioridazine to be greater than chlorpromazine and also described disturbances of accommodation, diarrhea and urinary incontinence.
In summary, adequate studies have indicated that thioridazine is a useful drug in adults, with serious side effects occurring less frequently than with other phenorhiazines and rarely enough to terminate treament. However, the rarity of studies combining comparison with placebo and the use of objective measures of change should be noted.
Reports on the use of thioridazine in children are sparse indeed. Oettinger and Simonds (22) reported on 279 patients, most of whom were between the ages of five and 16 years, and treated for at least three months. Initial dosage of 10 mg. twice a day was increased until an effective dose was reached and varied from .5 to 3 mg. per kilo. in 24 hours. Children with the hyperkinetic hehaviour syndrome and retarded children with associated behaviour disturbances were reported as showing a "good" response in somewhat over one-third of the cases, a "fair" response in a similar proportion, about one-fifth were "unchanged" and the remainder were "worse". Children with convulsive disorders and associated behaviour disorders showed a "good" response in 18.7%, "fair" in 50%, "unchanged" in 18.7% and were "worse" in 12.6%. One of the latter patients developed more frequent seizures. Ratings were based on parents' and teachers' opinions and in some patients on Bender-Gestalt, and Goodenough Draw-a-Man tests. No double-blind procedure was used. Two boys, one aged 11 and one 14 years, developed extrapyramidal seizures on doses of less than 1 mg. per kilo. in 24 hours, administered for less than two weeks.
Zarling and Hogan (41) reported on the treatment of 21 hyperactive children, aged five to 16 years, with school maladjustment, treated with 10 mg. t.i.d. Results were evaluated by questionnaires to teachers and parents. The authors reported hyperactivity controlled in 63%, attention span increased in 79% and nervous tics and mannerisms reduced in 49% The study was uncontrolled; no side effects were reported.
Rentsch (28) reported on the use of the drug in 202 infants and children, aged two days to 15 years, with an average daily dosage of 1.5 to 2 mg. per kilo. given from 11 days to several months. The symptoms for which the drug was prescribed included states of fear, excitement and tension, psychoneurotic and psychosomatic disorders, post-operative restlessness, itching dermatoses, and habitual vomiting. The author reported "good" results in 74% of the cases and "satisfactory" in a further 18%. With cases of such mixed symptomatology and with no use of placebo, it is difficult indeed, to assess the relationship of the altered behaviour to the administration of the drug. No side effects were reported.
Renard et et (27) school problems. Chlorpromazine had been unsatisfactory because of side effects; there were none from thioridazine. Optimal dosage was around 4 mgm. per kilo./24 hours and continued from three weeks to five months. In 14 cases there was total control of symptoms, marked improvement in 12, and no change in eight. Hyperactivity and oppositional behaviour were diminished and socialization improved. The authors believed the drug would make more normal personality development possible but favourable environmental influences continued to be an essential part of treatment. Neither objective measures nor placebo were used.
LeVann (18) employed thioridazine in 97 institutionalized children of whom 89 were defective and showed hyperactivity, noisiness and disturbed sleep rhythm. Dosage varied from 10 mgm. t.i.d. to 200 mgm. q.i.d. After three months 90% of the children were reported as showing "either complete or great improvement". Conclusions are difcult to draw since the study was uncontrolled and objective measures of behaviour not utilized. There were no reported side effects.
The necessity, therefore, for carefully controlled objective studies of what appears to be a very safe phenothiazine in child psychiatry is apparent. A children's psychiatric hospital is an ideal setting for such a study because control or awareness of significant variablesIs more practicable than for an out-patient population and it is more possible to employ objective measures of behaviour.
The present study was meant to provide a controlled, critical trial of the drug. This implied that three treatment conditions,-drug, placebo and nothingwere used, that changes must be meaningful in terms of day-to-day behaviour and that the measurement of such changes be objective and quantifiable.
Method

(a) Subjects
Nine male patients, three on each of three wards at Thistletown Hospital, were selected for the study; three were mild brain damage cases, six primary childhood behaviour disorders, but all showed marked aggressive behaviour and over-activity clinically. Eight were aged nine to 11Yz years, one was aged six years.
(b) Experimental Design
The design of the study was doubleblind with three experimental conditions, each of three weeks' duration; a no-drug condition, placebo condition, and a drug condition (25 mgm. t.i.d.) were used. 
N8 N9
IN denotes nothing administered but observations taken, P indicates placeho and D, thioridazine The study was replicated on the three wards and in addition, patients entered the treatment conditions at one-week intervals so that changes in milieu would not bias the results. Table I shows the design in detail. As can be seen each subject serves as his own control.
It was decided to investigate five main variables -aggressive, affectionate, constructive and destructive behaviour and activity level. Aggressive and affectionate behaviour were further subdivided into verbal and physical, and staff-directed and peer-directed categories.
To provide the information on the effect of the medication on motor variables in an objective and quantifiable form, a time sample observation sheet was devised. A sample of this sheet appears at the end of the paper. Observers were trained and instructed to complete the sheets at the times indicated. Patients were observed daily, Monday through Friday, between 9 a.m. and 7 p.m., during seven three-minute periods selected from a table of random numbers. The week's schedule was replicated nine times for the duration of the study, giving a weekly total of 35 and a nine-week tot-al of 315 samples for each child. The completed samples were collected daily so that observers could not compare changes: at no time were ward staff aware of the experimental condition.
Results
The study provided 2,835 completed time samples with 36,855 items of data for analysis. Results are provided in this paper for the five main variables only, with results for sub-classifications to appear in a later article.
A Friedman Two-Way analysis of variance (32) was carried out for the five main variables with each of the activity level categories analysed separately. The results of these analyses appear in Table II . As can be seen, significant differences occurred between the number of observed incidents in different weeks for aggressive behaviour, destructive behaviour and all three activity levels, while there were no differences in the frequency of affectionate behaviour and constructive behaviour. In this subject sample, therefore, no changes in affectionate and constructive behaviour could be associated with the administration of thioridazine.
To point up the effects of the drug the variables, where overall significant differences did occur, were analysed further, using the Wilcoxon Matched Pairs Signed Ranks Test. Figure 1 shows the total aggressive behaviour observed in nine subjects (315 samples) under each treatment condition during the nine weeks of the study. As can be seen from the graph, the administration of thioridazine reduced aggressive behaviour considerably: the three drug weeks are 53% lower in aggression than all non-drug weeks and 61% lower in aggression than the three weeks prior to any drug administration. The drug weeks show significantly lower levels of aggressive behaviour than all other conditions except Nothing 8. w.ek Figure 2 shows the total destructive behaviour observed in nine subjects under each treatment condition during the nine weeks of the study. Again the effect of thioridazine is clear, reducing destructive behaviour by 55% if all non-drug weeks are used as a baseline, and 66% if the pre-drug weeks are used. Drug weeks showed a significantly lower level of destructive behaviour than Weeks 1, 2, and 3, but differences for Weeks 5, 8 and 9, although in the predicted direction, did not reach significance probably because of the delay required for the elimination of the drug.
The pattern for the "more active than usual" category followed that for variables previously discussed: it was used significantly fewer times when the subjects were taking thioridazine than in other experimental conditions. The remaining two categories show significant drug trends only for Week 4 where the drug appears to have had an initial sedative effect, which did not persist in ensuing drug weeks.
Discussion
The results clearly indicate that thioridazine 25 mg. t.i.d. had a marked affect in reducing aggressive behaviour, destructive behaviour and over-activity. In eight of the subjects this represented a dosage of between 2 mg. and 2.7 mg. per kilo. per 24 hours.
The only side effect likely to be attributable to the drug was status epilepticus in the ninth subject in whom the dosage was 4.1 mg. per kilo. for 24 hours. Status had occurred before admission (seven months after brain injury) and twice during the six months' hospitalization; on the first occasion 48 hours after beginning dextroamphetamine sulphate, and on the second occasion 72 hours after commencing the thioridazine. Diphenylhydantoin sodium was raised from 1 grain t.i.d. to 1 grain q.i.d. and the trial continued without incident. There was a noticeable lack of hypnotic effect in the subjects and no evidence of parkinsonism observed. 244 THE CANADIAN PSYCHIATRIC JOURNAL Vol. 9, No.3 Our view is that justification for the use of such drugs in child psychiatry does not rest upon theoretical considerations concerning the role of organic, biochemicalor physiological brain disturbances. Neither the dichotomy of organic versus psychological etiology, nor that of pharmacological versus psychological treatment, can be regarded as valid.
Whatever the relative importance etiologically of environmental-interpersonal influences and physiological-organic factors, persistent patterns of maladaptive behaviour have two major effects. Firstly, the severity may be such that environmental therapeutic influences are unable to modify the disturbance significantly, or do so more slowly 'Or less effectively than if the symptoms are controlled pharmacologically. Secondly, there are many secondary effects of severe disturbance which tend to perpetuate or increase the difficulties by resulting in deleterious parental (or staff), peer or community attitudes, school failure, feelings of hopelessness and low self-image in the child, etc. The primary clinical questions to be answered are:
Observer's Name
Child's Name: John Doe Date: March 1, 1963 Time: 9.00 -9.03
The task for the observer is a simple one. He or she is to observe the child for a three-minute period beginning exactly at the time listed above and on the basis of this observation answer the ten questions, below and complete the one rating.
Circle (present or absent) whether any of the behaviour listed below took place during the threeminute period. All ten questions and the rating scale must be answered for each time period. (l) Is the medication effective incertain patterns of disturbance when various etiological constellations are present? (2) Does the use of such medication result in gains beyond those attributable to the immediate effects of the drug and greater than those resulting from the therapeutic influences apart from the drug? The answer to the first question is clearly "yes". There is evidence that this is also true of the second question, for example, the improved school performance noted by Oettinger and Simonds.
It would seem extremely likely on theoretical grounds that the presence of severe disorganizing anxiety or hostility, markedly increased impulsivity, short attention span or hyperactivity would reduce the child's capacity to establish new and more adaptive patterns of feeling and action. This is a question of considerable importance to a children's residential treatment centre and will be the subject of further studies. Medication is thus seen not as a substitute for environmental-psychological treatment influences but a possible means of making these more effective.
Summary
Studies on the use of thioridazine in adults and children were reviewed and the paucity of the controlled objective investigated, observed.
Thioridazine in doses of 25 mg. t.i.d. was administered to nine children with persistent marked aggressivity and hyperactivity. A double-blind study revealed a considerable reduction in aggressive, destructive and hyperactive behaviour. Status epilepticus occurred in an epileptic boy, necessitating an increase in anticonvulsant medication. No other side effects were observed.
It is concluded that thioridazine is a safe and useful drug in the treatment of hyperactive, aggressive, destructive patterns of behaviour in children.
